Invention Grant
![Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases](/docs/US/2020-02-11/US10555933B2/abs.jpg.600x600.jpg)
- Patent Title: Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
-
Application No.: US16127034Application Date: 2018-09-10
-
Publication No.: US10555933B2Publication Date: 2020-02-11
- Inventor: Mohammed I. Dibas , John E. Donello , Daniel W. Gil
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: A61K31/4174
- IPC: A61K31/4174
![Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases](/abs-image/US/2020/02/11/US10555933B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to pharmaceutical compositions, containing 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, (S) 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole or (S) [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol, their use as pharmaceuticals for the treatment of retinal diseases, for retinal neuroprotection and vision enhancement.
Public/Granted literature
Information query
IPC分类:
